Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-
B5056 L-733,060 hydrochlorideSummary: Potent NK1 antagonist
-
B5127 Hemokinin 1 (mouse)Summary: agonist at the tachykinin NK1 receptor
-
B5161 GR 82334Summary: Tachykinin NK1 receptor antagonist
-
B5169 Spantide ISummary: Selective NK1 receptor antagonist
-
B5240 C14TKL-1Summary: potent agonist for NK1 receptors
-
B5300 FK 888Summary: Selective, high affinity tachykinin NK1 receptor antagonist
-
B5318 Hemokinin 1 (human)Summary: selective agonist at the tachykinin NK1 receptor
-
B6478 L-732,138Summary: tachykinin NK1 receptor antagonist
-
B6810 RP 67580Summary: tachykinin NK1 receptor antagonist